ERVW-1 and infection: Within 2 months of infection both individuals developed detectable neutralizing Ab activity against the T/F Env, and by day 73/60 robust IC50 titers of 1∶4500 (R880F) and 1∶720 (R463F) were present (Fig. 4A).